Objective: To compare low-dose botulinum toxin injections followed by short-term electrical stimulation with high-dose botulinum toxin for poststroke spastic drop foot. Design: Twelve patients with spastic drop foot were randomly assigned to two treatment groups. The first group (n = 6) received low-dose (100 Units) botulinum toxin injection to the posterior tibial muscle in combination with short-term electrical stimulation, and the second group (n = 6) received a total of 400 units of botulinum toxin injections in equal doses to the posterior tibial, soleus, medial, and lateral gastrocnemius muscles. The patients were evaluated before and 2, 4, 8, and 12 wks after the treatment by the following variables: resting position angle, active a...
Botulinum toxin A (BoNT-A) has been shown effective for poststroke lower limb spasticity. Following ...
BACKGROUND AND OBJECTIVE: A wide range of adjunct therapies after botulinum toxin administration ha...
Objective To evaluate the therapeutic effect of botulinum toxin A (BTX-A) injection on spastic gastr...
OBJECTIVE: To evaluate the efficacy of a combined treatment for spastic foot using selective injecti...
OBJECTIVE: To investigate the effect of combined botulinum toxin type A (BTX) and functional electri...
Background. Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spast...
Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity and sh...
Objective Outcome differences between selective abobotulinumtoxin type A (aboBoNT/A) injections into...
The objective was to inform sample size calculations for a full randomized controlled trial (RCT). T...
Introduction. Several studies showed that electrical stimulation (ES) of the injected muscles enhanc...
The objective of this study was to quantify the increase in efficacy during the first four cycles of...
Post-stroke spasticity impedes patients’ rehabilitation progress. Contradictory evidence has been re...
Background and objective: A wide range of adjunct therapies after botulinum toxin administration hav...
Optimal treatment of spasticity requires a combination of pharmacotherapy and muscle lengthening. We...
No recommended guidelines currently exist for the therapeutic concentration or dose of botulinum tox...
Botulinum toxin A (BoNT-A) has been shown effective for poststroke lower limb spasticity. Following ...
BACKGROUND AND OBJECTIVE: A wide range of adjunct therapies after botulinum toxin administration ha...
Objective To evaluate the therapeutic effect of botulinum toxin A (BTX-A) injection on spastic gastr...
OBJECTIVE: To evaluate the efficacy of a combined treatment for spastic foot using selective injecti...
OBJECTIVE: To investigate the effect of combined botulinum toxin type A (BTX) and functional electri...
Background. Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spast...
Botulinum toxin type A (BoNT-A) injection is an effective treatment for lower-limb spasticity and sh...
Objective Outcome differences between selective abobotulinumtoxin type A (aboBoNT/A) injections into...
The objective was to inform sample size calculations for a full randomized controlled trial (RCT). T...
Introduction. Several studies showed that electrical stimulation (ES) of the injected muscles enhanc...
The objective of this study was to quantify the increase in efficacy during the first four cycles of...
Post-stroke spasticity impedes patients’ rehabilitation progress. Contradictory evidence has been re...
Background and objective: A wide range of adjunct therapies after botulinum toxin administration hav...
Optimal treatment of spasticity requires a combination of pharmacotherapy and muscle lengthening. We...
No recommended guidelines currently exist for the therapeutic concentration or dose of botulinum tox...
Botulinum toxin A (BoNT-A) has been shown effective for poststroke lower limb spasticity. Following ...
BACKGROUND AND OBJECTIVE: A wide range of adjunct therapies after botulinum toxin administration ha...
Objective To evaluate the therapeutic effect of botulinum toxin A (BTX-A) injection on spastic gastr...